Federal Member for Forrest and Assistant Minister for Regional Development and Territories Nola Marino has welcomed new and amended medicines listings on the Pharmaceutical Benefits Scheme (PBS), an extension to emergency dispensing measures to support patients during the COVID-19 pandemic, and other important health investments.
From 1 July the medicine Ozempic® (semaglutide) will be listed on the PBS as a new treatment option for type 2 diabetes.
In addition to this, the listing of Tecentriq® (atezolizumab) will be expanded and improved to include a new form and treatment regimen, to assist patients with small cell lung cancer.
The Government has also extended emergency measures for the dispensing of PBS medicines, to 30 September 2020.
“This expansion complements a number of recent Government funding commitments to the health sector, improving health outcomes in our South West,” Mrs Marino said.
“From 1 June 2020 South West residents with asthma and multiple myeloma have broader access to life-changing medicines as a result of expanded medicines listings on the PBS.
“This follows an earlier announcement in May for people with cardiovascular disease, rheumatoid arthritis and asthma, that new and amended medicines listings are now available on the PBS.
“All new listings on the PBS are about improving health and saving lives.
“As an Endometriosis Australia Ambassador I’m pleased to see our Government continuing its strong support for women and girls with endometriosis, investing more than $9.5 million in five innovative research projects.
“The Government will also provide $13.6 million to support ten clinical trials to find innovative cancer treatments for melanoma, reproductive and gynaecological cancers and childhood brain cancer.”